{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:57:30Z","timestamp":1789387050701,"version":"build-2803163510"},"reference-count":13,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":813,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/apt.12369","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T01:54:43Z","timestamp":1370915683000},"page":"284-293","source":"Crossref","is-referenced-by-count":32,"title":["Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis"],"prefix":"10.1111","volume":"38","author":[{"given":"S.","family":"Vegter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tolley","sequence":"additional","affiliation":[{"name":"Tolley Health Economics Consultancy Ltd; Buxton; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wilson Waterworth","sequence":"additional","affiliation":[{"name":"Atlantic Healthcare Ltd; Cambridge; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jones","sequence":"additional","affiliation":[{"name":"Atlantic Healthcare Ltd; Cambridge; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jones","sequence":"additional","affiliation":[{"name":"Atlantic Healthcare Ltd; Cambridge; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jewell","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine; University of Oxford; Oxford; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,10]]},"reference":[{"key":"10.1111\/apt.12369-BIB0001|apt12369-cit-0001","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2000.01940.x","article-title":"A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis","volume":"95","author":"Cohen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12369-BIB0002|apt12369-cit-0002","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/j.1572-0241.2000.02180.x","article-title":"Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis","volume":"95","author":"Marshall","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12369-BIB0003|apt12369-cit-0003","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.137.1.245","article-title":"Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)","volume":"137","author":"Dustin","year":"1986","journal-title":"J Immunol"},{"key":"10.1111\/apt.12369-BIB0004|apt12369-cit-0004","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.4049\/jimmunol.147.9.2913","article-title":"Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes","volume":"147","author":"Oppenheimer-Marks","year":"1991","journal-title":"J Immunol"},{"key":"10.1111\/apt.12369-BIB0005|apt12369-cit-0005","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1365-2036.2006.02909.x","article-title":"Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis","volume":"23","author":"Miner","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12369-BIB0006|apt12369-cit-0006","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1365-2036.2006.02837.x","article-title":"Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial","volume":"23","author":"Miner","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12369-BIB0007|apt12369-cit-0007","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/gut.2003.036160","article-title":"A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis","volume":"53","author":"Deventer","year":"2004","journal-title":"Gut"},{"key":"10.1111\/apt.12369-BIB0008|apt12369-cit-0008","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1365-2036.2006.02910.x","article-title":"A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis","volume":"23","author":"Deventer","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12369-BIB0009|apt12369-cit-0009","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/dom.12086","article-title":"A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials","volume":"15","author":"Freemantle","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/apt.12369-BIB0010|apt12369-cit-0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia-responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1111\/apt.12369-BIB0011|apt12369-cit-0011","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.12369-BIB0012|apt12369-cit-0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2036.2004.01863.x","article-title":"An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis","volume":"19","author":"Miner","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12369-BIB0013|apt12369-cit-0013","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1017\/S0266462308080471","article-title":"Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses","volume":"24","author":"Koopman","year":"2008","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12369","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.12369\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T09:16:16Z","timestamp":1688289376000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,10]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.12369","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,10]]}}}